Bloodwork question about hexarelin. Baseline, three years in, and the numbers moved in a direction I did not expect.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Water retention and mild lethargy in the first fortnight are the usual pattern.
Anyone got a paper worth reading on this rather than a write-up of a paper?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Lethargy in the first fortnight was my main issue with hexarelin too.
Stupid question: how do you know whether what is in the vial matches the label at all?
How long before you can reasonably say something is or is not doing anything? Same for me with hexarelin, unfortunately.
What is the first thing you would read if you were starting from zero?
Read methods.
What is the first thing you would read if you were starting from zero?
Same here.